| 000 | 01688 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250516113436.0 | ||
| 264 | 0 | _c20130523 | |
| 008 | 201305s 0 0 eng d | ||
| 022 | _a1541-2563 | ||
| 024 | 7 |
_a10.3109/15412555.2012.729623 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGotfried, Mark H | |
| 245 | 0 | 0 |
_aEfficacy of indacaterol 75 μg once-daily on dyspnea and health status: results of two double-blind, placebo-controlled 12-week studies. _h[electronic resource] |
| 260 |
_bCOPD _cDec 2012 |
||
| 300 |
_a629-36 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdministration, Inhalation |
| 650 | 0 | 4 |
_aAdrenergic beta-2 Receptor Agonists _xadministration & dosage |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAnalysis of Variance |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 |
_aDyspnea _xdrug therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aForced Expiratory Volume |
| 650 | 0 | 4 | _aHealth Status Indicators |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIndans _xadministration & dosage |
| 650 | 0 | 4 | _aLogistic Models |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPulmonary Disease, Chronic Obstructive _xcomplications |
| 650 | 0 | 4 |
_aQuinolones _xadministration & dosage |
| 650 | 0 | 4 | _aSurveys and Questionnaires |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aKerwin, Edward M | |
| 700 | 1 | _aLawrence, David | |
| 700 | 1 | _aLassen, Cheryl | |
| 700 | 1 | _aKramer, Benjamin | |
| 773 | 0 |
_tCOPD _gvol. 9 _gno. 6 _gp. 629-36 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3109/15412555.2012.729623 _zAvailable from publisher's website |
| 999 |
_c22143511 _d22143511 |
||